The current study elucidated the anti-rheumatic effect of visnagin through a significant inhibitory effect on MDH1 at the level of activity and gene expression with a significant decrease in RA biomarkers, inflammatory cytokines biomarkers, and the expression level of MMP-3 either alone or in combination with MTX. The gene discussed is MDH1; the disease is rheumatoid arthritis.